Fatty acid esters
Medchemexpress LLC L-octanoylcarnitine hydrochloride | 54377-02-5 | 98.0% | 323.86 g/mol | C15H30ClNO4 | 50 MG
L-Octanoylcarnitine hydrochloride is the hydrochloride salt of L-octanoylcarnitine, an endogenous plasma metabolite supplied as a research reagent for studies of fatty acid metabolism, cellular bioenergetics, and related biochemical assays. The material is intended for in vitro research and is provided with batch-specific analytical documentation for quality verification.
- Hydrochloride salt form for improved stability and handling.
- High purity: 98.0% (NMR).
- Molecular formula C15H30ClNO4; molecular weight 323.86 g/mol.
- Supplied in small research quantities, e.g., 50 MG.
- Batch-specific COA and datasheet available for quality assurance.
- For research use only; not for human consumption or clinical use.
Sigma Aldrich Fine Chemicals Biosciences Octanoyl L carnitine N met10MG
Octanoyl L carnitine N met10MG
Medchemexpress LLC Octanoyl-L-carnitine-d3 chloride | 1334532-24-9 | MFCD22419179 | 99.9% | 326.87 g/mol | C15H27D3ClNO4 | 5 MG
Octanoyl-L-carnitine-d3 chloride is the deuterium-labeled chloride salt of octanoyl-L-carnitine supplied as a solid stable-isotope standard for analytical and research use. It is intended as an internal standard for LC-MS/MS and GC-MS assays and for metabolic tracing studies of fatty acid and carnitine metabolism. The product is provided in small milligram packs suitable for reference standards and method development.
- Deuterium-labeled internal standard for mass spectrometry assays.
- Provided as the chloride salt for compatibility with aqueous and organic solvents.
- High purity suitable for quantitative analysis.
- Solid, white to off-white appearance for easy handling and storage.
- Supplied in small milligram quantities for reference standard use.
- Useful for metabolic tracing and quantification of acylcarnitines.
Medchemexpress LLC 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-(1-oxobutoxy)-, inner salt, (2R)- | 25576-40-3 | 99.9% | 231.29 | 50 MG
Butyrylcarnitine is an endogenous metabolite found in plasma. Elevated levels are associated with abnormalities in lipid and energy metabolism. It can serve as a diagnostic and prognostic indicator for diseases such as heart failure and head and neck cancer. It is for research use only and not sold to patients. Butyrylcarnitine promotes cell proliferation in HN30 cell line in a dose-dependent manner within a certain concentration range and can enhance the proliferation, migration, and invasion abilities of HN30 cells.
- Endogenous metabolite
- Appearance: solid
- Color: white to off-white
- Initial source: endogenous metabolite
- Structure classification: ketones, aldehydes, acids
- Soluble in H2O (≥ 100 mg/mL)
eMolecules 18877-64-0 | Medchem Express | L-Palmitoylcarnitine (chloride) | 5mg | 586608654 | HY-113147A | MFCD00070346 | 436.07 | C23H46ClNO4
Ambeed | 1-(Imidazo[12-a]pyridin-3-yl)ethanol | 1g | 573009189 | A916500 | 30489-50-0 | MFCD11908281 | 162.192 | C9H10N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Stearoylcarnitine | 25597-09-5 | 99.9% | 427.66 | 50 MG
Stearoylcarnitine is a fatty ester lipid molecule and an endogenous metabolite. It can act as a PKC inhibitor and accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse models. It also inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbit plasma and serves as a metabolomics biomarker for Parkinson's disease. Additionally, it is a less potent inhibitor of GlyT2.
- Functions as an endogenous metabolite.
- Acts as a PKC inhibitor.
- Accumulates in beta cells, impairing insulin synthesis.
- Inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbit plasma.
- Serves as a metabolomics biomarker for Parkinson's disease.
- Less potent inhibitor of GlyT2.
- Impairs mitochondrial energy metabolism in MIN6 cells.
- Alters brain acylcarnitine levels in a mouse model of hypoxic-ischemic brain injury.
Medchemexpress LLC Butyrylcarnitine | 25576-40-3 | 100.0% | 231.29 | 25 MG
Butyrylcarnitine is an endogenous metabolite found in plasma. Elevated levels are associated with abnormalities in lipid and energy metabolism. It can serve as a diagnostic and prognostic indicator for certain diseases, including heart failure and head and neck cancer.
- Endogenous metabolite.
- Associated with lipid and energy metabolism.
- Potential diagnostic and prognostic indicator for heart failure and head and neck cancer.
TARGETMOL CHEMICALS INC Dodecanoylcarnitine 25MG
Also available in 2 mg, 5 mg, 10 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. Dodecanoylcarnitine ((-)-Lauroylcarnitine) has been associated with disturbances in fatty acid oxidation, and the use of Dodecanoylcarnitine resulted in an increase in the permeability of salmon calcitonin. Purity 99.72%
Medchemexpress LLC L-Hexanoylcarnitine | 22671-29-0 | 99.9% | 259.34 | 100 MG
L-Hexanoylcarnitine is an acylcarnitine associated with celiac disease and functions as a human endogenous metabolite. It appears as an off-white to light yellow solid.
- Associated with celiac disease
- Functions as a human endogenous metabolite
- Off-white to light yellow solid appearance
- For research use only
[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C | 100mg | 517109166](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000192150.jpg-250.jpg)
eMolecules 745017-94-1 | Monomethyl Auristatin F | Combi-Blocks | MFCD25976742 | 731.976 | C39H65N5O8 | 95.000 | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C | 100mg | 517109166
Monomethyl Auristatin F | Combi-Blocks | 745017-94-1 | MFCD25976742 | 731.976 | C39H65N5O8 | 95.000 | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C | 100mg | 517109166
Medchemexpress LLC Stearate sodium 100g
Stearate sodiumIt is an organic compound belonging to fatty acids It is the sodium salt of stearic acid a saturated fatty acid commonly found in various animal and vegetable fats Stearate sodiumCommonly used as surfactants emulsifiers and detergents it is widely used in the cosmetics personal care and detergent industries It s found in a variety of products including soaps shampoos toothpaste and laundry detergent Also it has applications in the food industry where it is used as a food additive to improve texture and shelf life
Medchemexpress LLC Monomethyl auristatin E intermediate-1 | 120205-48-3 | 99.5% | 295.85 | 25 G
Monomethyl auristatin E intermediate-1 is an intermediate reagent used in the synthesis of Monomethyl auristatin E. Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity and is widely utilized as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs).
- Intermediate reagent in the synthesis of Monomethyl auristatin E.
- Inhibits microtubules and tubulin.
- Exhibits anticancer activity.
- Used as the cytotoxic component of antibody-drug conjugates.
Medchemexpress LLC MRK-623 | 461449-78-5 | 97.0% | 348.37 g·mol^-1 | C20H17FN4O | 50MG
MRK-623 is an orally active, high-affinity GABAA receptor agonist used for laboratory research. It shows anxiolytic effects and potent affinity for multiple GABAA subunits (reported Ki values: α1 0.85 nM; α2 3.7 nM; α3 4.0 nM; α5 0.53 nM).
Medchemexpress LLC MK-0812 (Succinate) | 851916-42-2 | 99.9% | C28H40F3N3O7 | 1 ML
MK-0812 Succinate is a potent and selective CCR2 antagonist with high affinity at CCR2. It is for research use only and not sold to patients. Key features include:
- Completely blocks MCP-1 mediated responses (IC50 3.2 nM)
- Inhibits 125I-MCP-1 binding on isolated monocytes (IC50 4.5 nM)
- Inhibits monocyte shape change in rhesus blood (IC50 8 nM)
- Reduces frequency of Ly6G-Ly6Chi monocytes in peripheral blood
- Causes a dose-dependent reduction in circulating Ly6Chi monocytes
- Elevates CCR2 ligand CCL2